<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<!--The publisher of this article does not allow downloading of the full text in XML form.-->
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Am J Physiol Heart Circ Physiol</journal-id>
<journal-id journal-id-type="iso-abbrev">Am. J. Physiol. Heart Circ. Physiol</journal-id>
<journal-id journal-id-type="pmc">ajpheart</journal-id>
<journal-id journal-id-type="publisher-id">Am J Physiol Heart Circ Physiol</journal-id>
<journal-id journal-id-type="publisher-id">AJPHEART</journal-id>
<journal-title-group>
<journal-title>American Journal of Physiology - Heart and Circulatory Physiology</journal-title>
</journal-title-group>
<issn pub-type="ppub">0363-6135</issn>
<issn pub-type="epub">1522-1539</issn>
<publisher>
<publisher-name>American Physiological Society</publisher-name>
<publisher-loc>Bethesda, MD</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">30387679</article-id>
<article-id pub-id-type="pmc">6383360</article-id>
<article-id pub-id-type="publisher-id">H-00531-2018</article-id>
<article-id pub-id-type="publisher-manuscript">H-00531-2018</article-id>
<article-id pub-id-type="doi">10.1152/ajpheart.00531.2018</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<series-title>Integrative Cardiovascular Physiology and Pathophysiology</series-title>
</article-categories>
<title-group>
<article-title>The nuclear receptor RORα protects against angiotensin II-induced cardiac hypertrophy and heart failure</article-title>
<alt-title alt-title-type="running-head">NUCLEAR RECEPTOR RORα REGULATES CARDIAC HYPERTROPHY</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Beak</surname>
<given-names>Ju Youn</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Kang</surname>
<given-names>Hong Soon</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Huang</surname>
<given-names>Wei</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Myers</surname>
<given-names>Page H.</given-names>
</name>
<xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Bowles</surname>
<given-names>Dawn E.</given-names>
</name>
<xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Jetten</surname>
<given-names>Anton M.</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0001-6430-8344</contrib-id>
<name>
<surname>Jensen</surname>
<given-names>Brian C.</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="aff5">
<sup>5</sup>
</xref>
</contrib>
<aff id="aff1"><sup>1</sup><institution>McAllister Heart Institute University of North Carolina School of Medicine</institution>, <addr-line>Chapel Hill, North Carolina</addr-line></aff>
<aff id="aff2"><sup>2</sup>Immunity, Inflammation and Disease Laboratory, National Institute of Environmental Health Sciences, <institution>National Institutes of Health</institution>, <addr-line>Research Triangle Park, North Carolina</addr-line></aff>
<aff id="aff3"><sup>3</sup>Veterinary Medicine Section, Comparative Medicine Branch, National Institute of Environmental Health Sciences, <institution>National Institutes of Health</institution>, <addr-line>Research Triangle Park, North Carolina</addr-line></aff>
<aff id="aff4"><sup>4</sup>Department of Surgery, <institution>Duke University Medical Center</institution>, <addr-line>Durham, North Carolina</addr-line></aff>
<aff id="aff5"><sup>5</sup>Division of Cardiology, University of North Carolina School of Medicine, Chapel Hill, North Carolina</aff>
</contrib-group>
<author-notes>
<corresp id="cor1">Address for reprint requests and other correspondence: B. C. Jensen, Div. of Cardiology, Univ. of North Carolina, 160 Dental Circle, CB 7075 Chapel Hill, NC 27599-7075 (e-mail: <email>bcjensen@med.unc.edu</email>).</corresp>
</author-notes>
<pub-date pub-type="ppub">
<day>1</day>
<month>1</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="epub">
<day>2</day>
<month>11</month>
<year>2018</year>
</pub-date>
<volume>316</volume>
<issue>1</issue>
<fpage>H186</fpage>
<lpage>H200</lpage>
<history>
<date date-type="received">
<day>6</day>
<month>8</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>4</day>
<month>10</month>
<year>2018</year>
</date>
<date date-type="accepted">
<day>19</day>
<month>10</month>
<year>2018</year>
</date>
</history>
<self-uri content-type="pdf" xlink:href="ajpheart.00531.2018.pdf"></self-uri>
<abstract>
<p>The nuclear receptor retinoic acid-related orphan receptor-α (RORα) regulates numerous critical biological processes, including central nervous system development, lymphocyte differentiation, and lipid metabolism. RORα has been recently identified in the heart, but very little is known about its role in cardiac physiology. We sought to determine whether RORα regulates myocardial hypertrophy and cardiomyocyte survival in the context of angiotensin II (ANG II) stimulation. For in vivo characterization of the function of RORα in the context of pathological cardiac hypertrophy and heart failure, we used the “staggerer” (RORα<sup>sg/sg</sup>) mouse, which harbors a germline mutation encoding a truncated and globally nonfunctional RORα. RORα<sup>sg/sg</sup> and wild-type littermate mice were infused with ANG II or vehicle for 14 days. For in vitro experiments, we overexpressed or silenced RORα in neonatal rat ventricular myocytes (NRVMs) and human cardiac fibroblasts exposed to ANG II. RORα<sup>sg/sg</sup> mice developed exaggerated myocardial hypertrophy and contractile dysfunction after ANG II treatment. In vitro gain- and loss-of-function experiments were consistent with the discovery that RORα inhibits ANG II-induced pathological hypertrophy and cardiomyocyte death in vivo. RORα directly repressed IL-6 transcription. Loss of RORα function led to enhanced IL-6 expression, proinflammatory STAT3 activation (phopho-STAT3 Tyr<sup>705</sup>), and decreased mitochondrial number and function, oxidative stress, hypertrophy, and death of cardiomyocytes upon ANG II exposure. RORα was less abundant in failing compared with nonfailing human heart tissue. In conclusion, RORα protects against ANG II-mediated pathological hypertrophy and heart failure by suppressing the IL-6-STAT3 pathway and enhancing mitochondrial function.</p>
<p><bold>NEW &amp; NOTEWORTHY</bold> Mice lacking retinoic acid-related orphan receptor-α (RORα) develop exaggerated cardiac hypertrophy after angiotensin II infusion. Loss of RORα leads to enhanced IL-6 expression and NF-κB nuclear translocation. RORα maintains mitochondrial function and reduces oxidative stress after angiotensin II. The abundance of RORα is reduced in failing mouse and human hearts.</p>
</abstract>
<kwd-group>
<kwd>angiotensin II</kwd>
<x xml:space="preserve">; </x>
<kwd>fibroblasts</kwd>
<x xml:space="preserve">; </x>
<kwd>group F, member 1</kwd>
<x xml:space="preserve">; </x>
<kwd>hypertrophy</kwd>
<x xml:space="preserve">; </x>
<kwd>left ventricular</kwd>
<x xml:space="preserve">; </x>
<kwd>mitochondria</kwd>
<x xml:space="preserve">; </x>
<kwd>nuclear</kwd>
<x xml:space="preserve">; </x>
<kwd>nuclear receptor subfamily 1</kwd>
<x xml:space="preserve">; </x>
<kwd>retinoic acid-related orphan receptor-α</kwd>
<x xml:space="preserve">; </x>
<kwd>signal transducer and activator of transcription 3</kwd>
</kwd-group>
<funding-group>
<award-group id="award1">
<funding-source>
<named-content content-type="funder-name">HHS | NIH | National Heart, Lung, and Blood Institute (NHBLI)</named-content>
<named-content content-type="funder-identifier">10.13039/100000050</named-content>
</funding-source>
<award-id>R01HL140067</award-id>
</award-group>
<award-group id="award2">
<funding-source>
<named-content content-type="funder-name">American Heart Association (AHA)</named-content>
<named-content content-type="funder-identifier">10.13039/100000968</named-content>
</funding-source>
<award-id>17GRNT33710008</award-id>
</award-group>
<award-group id="award3">
<funding-source>
<named-content content-type="funder-name">HHS | NIH | National Institute of Environmental Health Sciences (NIEHS)</named-content>
<named-content content-type="funder-identifier">10.13039/100000066</named-content>
</funding-source>
<award-id>Z01-ES-101586</award-id>
</award-group>
</funding-group>
</article-meta>
</front>
</article>
</pmc-articleset>